These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 33025411)
1. Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe? Frohlich J; Vinciguerra M Geroscience; 2020 Dec; 42(6):1475-1498. PubMed ID: 33025411 [TBL] [Abstract][Full Text] [Related]
2. Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects? Harper SC; Brack A; MacDonnell S; Franti M; Olwin BB; Bailey BA; Rudnicki MA; Houser SR Circ Res; 2016 Apr; 118(7):1143-50; discussion 1150. PubMed ID: 27034276 [TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor 11: A proangiogenic drug as a potential antiaging regulating molecule. Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C Arch Cardiovasc Dis; 2023 Jan; 116(1):41-46. PubMed ID: 36572608 [TBL] [Abstract][Full Text] [Related]
4. The Growth Differentiation Factor 11 (GDF11) and Myostatin (MSTN) in tissue specific aging. Fan X; Gaur U; Sun L; Yang D; Yang M Mech Ageing Dev; 2017 Jun; 164():108-112. PubMed ID: 28472635 [TBL] [Abstract][Full Text] [Related]
5. GDF11 does not rescue aging-related pathological hypertrophy. Smith SC; Zhang X; Zhang X; Gross P; Starosta T; Mohsin S; Franti M; Gupta P; Hayes D; Myzithras M; Kahn J; Tanner J; Weldon SM; Khalil A; Guo X; Sabri A; Chen X; MacDonnell S; Houser SR Circ Res; 2015 Nov; 117(11):926-32. PubMed ID: 26383970 [TBL] [Abstract][Full Text] [Related]
6. The role of GDF11 during inflammation - An overview. Machelak W; Szczepaniak A; Jacenik D; ZieliĆska M Life Sci; 2023 Jun; 322():121650. PubMed ID: 37011872 [TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11. McCoy JC; Walker RG; Murray NH; Thompson TB J Biol Chem; 2019 Apr; 294(16):6333-6343. PubMed ID: 30814254 [TBL] [Abstract][Full Text] [Related]
8. Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation. Walker RG; Poggioli T; Katsimpardi L; Buchanan SM; Oh J; Wattrus S; Heidecker B; Fong YW; Rubin LL; Ganz P; Thompson TB; Wagers AJ; Lee RT Circ Res; 2016 Apr; 118(7):1125-41; discussion 1142. PubMed ID: 27034275 [TBL] [Abstract][Full Text] [Related]
9. Structural basis for potency differences between GDF8 and GDF11. Walker RG; Czepnik M; Goebel EJ; McCoy JC; Vujic A; Cho M; Oh J; Aykul S; Walton KL; Schang G; Bernard DJ; Hinck AP; Harrison CA; Martinez-Hackert E; Wagers AJ; Lee RT; Thompson TB BMC Biol; 2017 Mar; 15(1):19. PubMed ID: 28257634 [TBL] [Abstract][Full Text] [Related]
10. Targeted Approach to Distinguish and Determine Absolute Levels of GDF8 and GDF11 in Mouse Serum. Camparini L; Kollipara L; Sinagra G; Loffredo FS; Sickmann A; Shevchuk O Proteomics; 2020 Jun; 20(11):e1900104. PubMed ID: 32104967 [TBL] [Abstract][Full Text] [Related]
11. Relationship of Circulating Growth and Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry With Age and Skeletal Muscle Strength in Healthy Adults. Semba RD; Zhang P; Zhu M; Fabbri E; Gonzalez-Freire M; Carlson OD; Moaddel R; Tanaka T; Egan JM; Ferrucci L J Gerontol A Biol Sci Med Sci; 2019 Jan; 74(1):129-136. PubMed ID: 30380014 [TBL] [Abstract][Full Text] [Related]
12. GDF11: An emerging therapeutic target for liver diseases and fibrosis. Habibi P; Falamarzi K; Ebrahimi ND; Zarei M; Malekpour M; Azarpira N J Cell Mol Med; 2024 Apr; 28(7):e18140. PubMed ID: 38494851 [TBL] [Abstract][Full Text] [Related]
14. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice. Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057 [TBL] [Abstract][Full Text] [Related]
15. GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells. Ge G; Hopkins DR; Ho WB; Greenspan DS Mol Cell Biol; 2005 Jul; 25(14):5846-58. PubMed ID: 15988002 [TBL] [Abstract][Full Text] [Related]
16. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. McPherron AC; Lawler AM; Lee SJ Nat Genet; 1999 Jul; 22(3):260-4. PubMed ID: 10391213 [TBL] [Abstract][Full Text] [Related]
17. Administration of rGDF11 retards the aging process in male mice via action of anti-oxidant system. Zhou Y; Song L; Ni S; Zhang Y; Zhang S Biogerontology; 2019 Aug; 20(4):433-443. PubMed ID: 30726519 [TBL] [Abstract][Full Text] [Related]
18. Relationships of GDF8 and 11 and Their Antagonists With Decline of Grip Strength Among Older Adults in the Baltimore Longitudinal Study of Aging. Yamaguchi Y; Zhu M; Moaddel R; Palchamy E; Ferrucci L; Semba RD J Gerontol A Biol Sci Med Sci; 2023 Oct; 78(10):1793-1798. PubMed ID: 37235639 [TBL] [Abstract][Full Text] [Related]
19. GDF11/BMP11 activates both smad1/5/8 and smad2/3 signals but shows no significant effect on proliferation and migration of human umbilical vein endothelial cells. Zhang YH; Cheng F; Du XT; Gao JL; Xiao XL; Li N; Li SL; Dong de L Oncotarget; 2016 Mar; 7(11):12063-74. PubMed ID: 26919250 [TBL] [Abstract][Full Text] [Related]